Reaction: Cladribine to 1 product

Reaction
Cladribine
DB00242
Cladribine 5'-monophosphate
DBMET03774
Reaction type
phosphorylation
Direction
Major circulating metabolite?
No
Spontaneous?
No
Activity
unknown
References
  1. DailyMed Label: Cladribine Intravenous Injection [Link]
  2. FDA Approved Drug Products: MAVENCLAD (cladribine) tablets, for oral use (December 2023) [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Deoxycytidine kinaseNot AvailableNot Availableimplied
Deoxyguanosine kinase, mitochondrialNot AvailableNot Availableimplied